Used primarily as a key intermediate in the synthesis of pharmaceutical agents targeting central nervous system disorders. Its structure supports the development of serotonin receptor modulators, particularly 5-HT3 and 5-HT4 receptor agonists or antagonists, which are relevant in treating conditions like irritable bowel syndrome, depression, and nausea. The chiral center enhances selectivity in drug design, improving efficacy and reducing side effects. Commonly employed in research settings for developing novel neuroactive compounds and in medicinal chemistry for structure-activity relationship studies.